DevinskyOHonigfeldGPatinJ.Clozapine related seizures. Neurology1991;41:369–71.
2.
PaciaSVDevinskyO.Clozapine related seizures: Experience with 5629 patients. Neurology1994;44:2247–9.
3.
TothPFrankenburgFR. Clozapine and seizures: A review. Can J Psychiatry1994;39:236–8.
4.
MatsudaKTChoMCLinKMSmithMYoungAAdamsJ.Clozapine dosage, serum levels, efficacy and side effect profiles: A comparison of Korean-American and Caucasian patients. Psychopharmacol Bull1996;32:253–7.
5.
CentorrinoFBaldessariniRJKandoJCFrankenburgFRVolpicelliSAFloodJG. Clozapine and metabolites: Concentrations in serum and clinical findings during treatment of chronically psychotic patients. J Clin Psychopharmacol1994;14:119–25.
6.
RemafediG.Male homosexuality: The adolescent's perspective. Pediatrics1987;79:326–30.
7.
RemafediG.Adolescent homosexuality: Issues for pediatricians. Clin Pediatr1985;24:481–5.
8.
RemafediG.Adolescent homosexuality: Psychosocial and medical implications. Pediatrics1987;79:331–7.
9.
ZuckerKJBradleySJ. Homosexuality in adolescents in gender identity disorder and psychosexual problems in children and adolescents. New York: Guilford; 1995. p 339–53.
10.
PrenzlauerSDrescherJWinchelR.Suicide among homosexual youth [letter]. Am J Psychiatry1992;149:1416–7.
11.
RemafediGFarrowJADeisherRW. Risk factors for attempted suicide in gay and bisexual youth. Pediatrics1991;87:869–75.
12.
McKeithIFairbairnAPerryRThompsonPPerryE.Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ1992;305:673–8.
13.
AllenRLWalkerZD'AthPJKatonaCLE. Risperidone for psychotic and behavioural symptoms in Lewy body dementia [letter]. Lancet1995;346:185.
14.
McKeithICBallardCG. Harrison RWS. Neuroleptic sensitivity to risperidone in Lewy body dementia [letter]. Lancet1995;346:699.
15.
LevyREaggerSGriffithsMPerryEHonaverMDeanA, and others. Lewy bodies and response to tacrine in Alzheimer's disease [letter]. Lancet1994;343:176.
16.
KusumakarVYathamLNHaslamDRSParikhSVMatteRSharmaV, and others. The treatment of bipolar disorder: Review of the literature, guidelines, and options. Can J Psychiatry1997:42(2 Suppl):69S–100S.
17.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed.Washington (DC): American Psychiatric Press; 1994. p 328–38.
18.
BeydounAUthmanBMSackellaresJC. Gabapentin: Pharmacokinetics, efficacy and safety. Clin Neuropharmacol1995;18:469–81.
19.
MarsaGWGoffinetDRRubinsteinLJBagshawMA. Megavoltage irradiation in the treatment of gliomas of the brain and spinal cord. Cancer1975;36:1681–9.
20.
PollakLKleinCRabeyJMSchifferJ.Posterior fossa lesions associated with neuropsychiatric symptomatology. Int J Neurosci1996;87:119–26.
21.
KanRMoriYSuzukiSOnoTTakahashiYKumashiroH.A case of temporal lobe astrocytoma associated with epileptic seizures and schizophrenia-like psychosis. Japan Journal of Psychiatry and Neurology1989;43:97–103.
22.
SolomonS.Neoplasms of the brain. In: KaplanHISadockBJ, editors. Comprehensive textbook of psychiatry IV. Baltimore (MD): Williams and Wilkins; 1985. p 105–10.
23.
LehmannHEBanTA. The history of the psychopharmacology of schizophrenia. Can J Psychiatry1997;42:152–62.
24.
DelayJDenikerPHarlJM. Traitment des états d'excitation et d'agitation par une méthode médicamenteuse derivée l'hibernothérapie. Les Annales médico-psychologiques1952;110:267–73.
HarmonJParaireJVelluzJ.Remarques sur l'action du 4560 RP sur l'agitation maniaque. Les Annales médico-psychologiques1952;110:331–5.
27.
DelayJDenikerP.Les neuroleptiques en thérapeutique psychiatrique. Thérapie1953;8:347–64.
28.
ShenWW. Pharmacotherapy of schizophrenia: The American current status. Keio J Med1994;43:192–200.
29.
HealyD.The psycopharmacologists. New York: Chapman and Hall; 1996.
30.
PichotP.The discovery of chlorpromazine and the place of psychopharmacology in the history of psychiatry. In: HealyD.The psychopharmacologists. New York: Chapman and Hall: 1996. p 1–27.
31.
SwazeyJP. Chlorpromazine in psychiatry: A study in therapeutic innovation. Cambridge (MA): MIT Press; 1974.
32.
LaboritHHuguenardPAlluaumeR.Un nouveau stabilisateur végétatif (le 4560 RP). Presse Med1952;60:206–8.
33.
LaboritHJaulmesC.De l'anesthésie potentialisée à l'hibernation artificielle. Toulouse Medicine1952;53:821–9.
34.
DechampsA.Hibernation artificielle en psychiatrie. Presse Med1952;60:944–6.
35.
HarmonJParaireJVelluzJ.Remarques sur l'action du 4560 RP sur l'agitation maniaque. Les Annales Médico-Psychologiques1952;110;331–5.
36.
LehmannHEBanTA. The history of the psychopharmacology of schizophrenia. Can J Psychiatry1997;42:152–62.